연구성과로 돌아가기

2021 연구자 정보 (128 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Baik, Hionsuck
(Baik, H) ⓘ 		Korea Basic Sci Inst KBSI, Seoul 02841, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Vertical-crystalline Fe-doped β-Ni oxyhydroxides for highly active and stable evolution reaction
[JCR상위 2.1] Crystal Phase Transition Creates a Highly Active and Stable RuCX Nanosurface for Hydrogen Evolution Reaction in Alkaline Media ⓘ 		SCIE ⓘ 2.1 MATERIALS SCIENCE, MULTIDISCIPLINARY
CHEMISTRY, MULTIDISCIPLINARY;CHEMISTRY, PHYSICAL;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, APPLIED;PHYSICS, CONDENSED MATTER ⓘ 		ysjn@kaist.ac.kr;hyung-suk.oh@kist.re.kr;sichoi@knu.ac.kr;kylee1@korea.ac.kr;
hklim@kangwon.ac.kr;ysyoun@yu.ac.kr;sichoi@knu.ac.kr; ⓘ
Bailey, Rochelle
(Bailey, R) ⓘ 		Bristol Myers Squibb, Princeton, NJ USA ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial ⓘ SCIE ⓘ 4.5 HEMATOLOGY;ONCOLOGY ⓘ fravandi@mdanderson.org; ⓘ
Chevassut, Timothy
(Chevassut, T) ⓘ 		Brighton & Sussex Med Sch, Brighton, E Sussex, England ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial ⓘ SCIE ⓘ 4.5 HEMATOLOGY;ONCOLOGY ⓘ fravandi@mdanderson.org; ⓘ
Choi, Changhyeok
(Choi, C) ⓘ 		Korea Adv Inst Sci & Technol KAIST, Dept Chem & Biomol Engn BK21 4, Daejeon 34141, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Vertical-crystalline Fe-doped β-Ni oxyhydroxides for highly active and stable evolution reaction ⓘ SCIE ⓘ 4.5 MATERIALS SCIENCE, MULTIDISCIPLINARY ⓘ ysjn@kaist.ac.kr;hyung-suk.oh@kist.re.kr;sichoi@knu.ac.kr;kylee1@korea.ac.kr; ⓘ
Dohner, Hartmut
(Döhner, H) ⓘ 		Ulm Univ Hosp, Dept Internal Med 3, Ulm, Germany ⓘ C-8933-2016
Döhner, Hartmut ⓘ
ⓘ 		[JCR상위 4.5] Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial ⓘ SCIE ⓘ 4.5 HEMATOLOGY;ONCOLOGY ⓘ fravandi@mdanderson.org; ⓘ
Dombret, Herve
(Dombret, H) ⓘ 		Hop St Louis, Assistance Publ Hop Paris AP HP, Paris, France
Univ Paris, Inst Rech St Louis, Paris, France ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial ⓘ SCIE ⓘ 4.5 HEMATOLOGY;ONCOLOGY ⓘ fravandi@mdanderson.org; ⓘ
Figuera-Alvarez, Angela
(Figuera-Alvarez, A) ⓘ 		Hosp Univ La Princesa, Madrid, Spain ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial ⓘ SCIE ⓘ 4.5 HEMATOLOGY;ONCOLOGY ⓘ fravandi@mdanderson.org; ⓘ
Hiwase, Devendra
(Hiwase, D) ⓘ 		Royal Adelaide Hosp, Adelaide, SA, Australia ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial ⓘ SCIE ⓘ 4.5 HEMATOLOGY;ONCOLOGY ⓘ fravandi@mdanderson.org; ⓘ
Jung, Yousung
(Jung, Y) ⓘ 		교신저자 Korea Adv Inst Sci & Technol KAIST, Dept Chem & Biomol Engn BK21 4, Daejeon 34141, South Korea ⓘ D-1676-2010
Jung, Yousung ⓘ
ⓘ 		[JCR상위 4.5] Vertical-crystalline Fe-doped β-Ni oxyhydroxides for highly active and stable evolution reaction ⓘ SCIE ⓘ 4.5 MATERIALS SCIENCE, MULTIDISCIPLINARY ⓘ ysjn@kaist.ac.kr;hyung-suk.oh@kist.re.kr;sichoi@knu.ac.kr;kylee1@korea.ac.kr; ⓘ
Kim, Byeongyoon
(Kim, B) ⓘ 		제1저자 Korea Univ, Dept Chem, Seoul 02841, South Korea
Korea Univ, Res Inst Nat Sci, Seoul 02841, South Korea ⓘ 		T-3659-2018
Kim, Byeongyoon ⓘ 		0000-0001-8399-727X
Kim, Byeongyoon ⓘ 		[JCR상위 4.5] Vertical-crystalline Fe-doped β-Ni oxyhydroxides for highly active and stable evolution reaction ⓘ SCIE ⓘ 4.5 MATERIALS SCIENCE, MULTIDISCIPLINARY ⓘ ysjn@kaist.ac.kr;hyung-suk.oh@kist.re.kr;sichoi@knu.ac.kr;kylee1@korea.ac.kr; ⓘ
La Torre, Ignazia
(La Torre, I) ⓘ 		Celgene Bristol Myers Squibb Co, Boudry, Switzerland ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial ⓘ SCIE ⓘ 4.5 HEMATOLOGY;ONCOLOGY ⓘ fravandi@mdanderson.org; ⓘ
Lee, Jaewan
(Lee, J) ⓘ 		Korea Adv Inst Sci & Technol KAIST, Dept Chem & Biomol Engn BK21 4, Daejeon 34141, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Vertical-crystalline Fe-doped β-Ni oxyhydroxides for highly active and stable evolution reaction ⓘ SCIE ⓘ 4.5 MATERIALS SCIENCE, MULTIDISCIPLINARY ⓘ ysjn@kaist.ac.kr;hyung-suk.oh@kist.re.kr;sichoi@knu.ac.kr;kylee1@korea.ac.kr; ⓘ
Lin, Zhiqun
(Lin, ZQ) ⓘ 		Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA ⓘ GPF-4115-2022
Lin, Zhiqun ⓘ
ⓘ 		[JCR상위 4.5] Enabling the Selective Detection of Endocrine-Disrupting Chemicals via Molecularly Surface-Imprinted "Coffee Rings" ⓘ SCIE ⓘ 4.5 BIOCHEMISTRY & MOLECULAR BIOLOGY;CHEMISTRY, ORGANIC;POLYMER SCIENCE ⓘ jinpark@knu.ac.kr;swhong@pusan.ac.kr; ⓘ
Lone, Saifullah
(Lone, S) ⓘ 		Pusan Natl Univ, Coll Nanosci & Nanotechnol, Dept Cognomechatron Engn, Dept Opt & Mechatron Engn, Busan 46241, South Korea ⓘ AAT-7811-2020
Lone, Saifullah ⓘ
ⓘ 		[JCR상위 4.5] Enabling the Selective Detection of Endocrine-Disrupting Chemicals via Molecularly Surface-Imprinted "Coffee Rings" ⓘ SCIE ⓘ 4.5 BIOCHEMISTRY & MOLECULAR BIOLOGY;CHEMISTRY, ORGANIC;POLYMER SCIENCE ⓘ jinpark@knu.ac.kr;swhong@pusan.ac.kr; ⓘ
Montesinos, Pau
(Montesinos, P) ⓘ 		Hosp Univ & Politecn La Fe, Valencia, Spain ⓘ GYU-2673-2022
Montesinos, Pau ⓘ 		0000-0002-3275-5593
Montesinos, Pau ⓘ 		[JCR상위 4.5] Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial ⓘ SCIE ⓘ 4.5 HEMATOLOGY;ONCOLOGY ⓘ fravandi@mdanderson.org; ⓘ
페이지 이동: